Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 13/20 | 0.53 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | RECQL | P46063 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29981135 | 0.94 | HPGD (0.54) | GPR119HPGDRECQLEPHX1USP2 | |
| SCHEMBL31496241 | 0.94 | GPR119 (0.61) | GPR119HPGDRECQLEPHX1USP2 | |
| SCHEMBL4008565 | 0.94 | HPGD (0.54) | GPR119HPGDRECQLEPHX1USP2 | |
| SCHEMBL13060395 | 0.92 | HPGD (0.66) | GPR119HPGDRECQL | |
| SCHEMBL31565588 | 0.91 | GPR119 (0.55) | GPR119HPGD | |
| SCHEMBL330785 | 0.91 | GPR119 (0.48) | GPR119HPGDRECQLEPHX1USP2 | |
| SCHEMBL66134 | 0.91 | GPR119 (0.48) | GPR119HPGDRECQLEPHX1USP2 | |
| SCHEMBL66145 | 0.91 | GPR119 (0.48) | GPR119HPGDRECQLEPHX1USP2 | |
| SCHEMBL21178227 | 0.88 | GPR119 (0.47) | GPR119HPGD | |
| SCHEMBL21192130 | 0.88 | GPR119 (0.47) | GPR119HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2336 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12552790-B2 | Positive modulators of the muscarinic acetylcholine receptor M4 | VANDERBILT UNIVERSITY (US) | 2026-02-17 | — | — | US | claimed |
| US-20250136600-A1 | POSITIVE MODULATORS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | VANDERBILT UNIVERSITY | 2025-05-01 | — | — | US | claimed |
| CN-111171023-B | Compound with Pim1 inhibitory activity and preparation method and medical application thereof | 中国药科大学 | 2021-12-21 | — | — | CN | claimed |
| CN-112225722-A | Method for preparing crizotinib intermediate by using microchannel reactor | 张家港威胜生物医药有限公司 | 2021-01-15 | — | — | CN | claimed |
| CN-111171023-A | Compound with Pim1 inhibitory activity and preparation method and medical application thereof | 中国药科大学 | 2020-05-19 | — | — | CN | claimed |
| US-20260146050-A1 | KRAS DEGRADING COMPOUNDS COMPRISING SPIROCYCLIC ANNULATED 2 AMINO-3-CYANO THIOPHENES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2026-05-28 | — | — | US | disclosed |
| EP-4747250-A1 | KINASE INHIBITORS | The United States Of America, As Represented By The Secretary, Department of Health and Human Services (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12637451-B2 | Amino quinazoline derivatives as P2X3 inhibitors | CHIESI FARMACEUTICI S.P.A. (IT) | 2026-05-26 | — | — | US | disclosed |
| CN-115943145-B | Pyrazolopyrimidine compounds as ATR kinase inhibitors | BEIJING TIDE PHARMACEUTICAL CO.,LTD. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-4743453-A1 | MODULATORS OF MITOCHONDRIAL DNA REPLICATION | Pretzel Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| EP-3364967-B1 | FERROPORTIN INHIBITORS | VIFOR INT AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-12629367-B2 | Five-membered ring-fused six-membered ring compound, preparation method therefor, and pharmaceutical composition and use thereof | HANGZHOU POLYMED BIOPHARMACEUTICALS, INC. (CN) | 2026-05-19 | — | — | US | disclosed |
| EP-0612729-A2 | Pyridine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1994-08-31 | — | — | EP | disclosed |
| CN-1077716-A | ANTIVIRAL PEPTIDES | PFIZER (US) | 1993-10-27 | — | — | CN | disclosed |
| US-5246948-A | Antiinflammatory, antipyretic, analgesic, antiallergic, immunosupressing or immunomodulating activity | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-09-21 | — | — | US | disclosed |
| WO-1993018003-A1 | SUBSTITUED PIPECOLINIC ACID DERIVATIVES AS HIV PROTEASE INHIBITORS | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1993-09-16 | — | — | WO | disclosed |
| EP-0560268-A1 | Substituted pipecolinic acid derivatives as HIV protease inhibitors | BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) | 1993-09-15 | — | — | EP | disclosed |
| EP-0522606-A2 | Pyridine derivatives, their production and use | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1993-01-13 | — | — | EP | disclosed |
| EP-0500835-A1 | A NOVEL QUINOLONE CARBOXYLIC ACID DERIVATIVE. | DAE WOONG PHARMA (KR) | 1992-09-02 | — | — | EP | disclosed |
| WO-1992004342-A1 | A NOVEL QUINOLONE CARBOXYLIC ACID DERIVATIVE | DAEWOONG PHARMACEUTICAL CO., LTD. (KR) | 1992-03-19 | — | — | WO | disclosed |